Jane Street’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Jane Street’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,510	Closed	-$107K	–	10839
2022 Q2	$107K	Sell	15,510 -18,270	-54%	-$128K	﹤0.01%	8602
2022 Q1	$314K	Buy	+33,780	New	+$360K	﹤0.01%	8328
2021 Q2	–	Sell	-22,448	Closed	-$629K	–	10721
2021 Q1	$629K	Buy	22,448 +7,552	+51%	+$272K	﹤0.01%	6379
2020 Q4	$520K	Buy	+14,896	New	+$649K	﹤0.01%	5682
2020 Q3	–	Sell	-27,739	Closed	-$1.29M	–	8222
2020 Q2	$1.29M	Buy	+27,739	New	+$1.2M	﹤0.01%	3698

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Jane Street's FMTX Position: Q3 2022 in Review

Jane Street sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 15,510 shares — an estimated $107K sold.

Jane Street first reported a position in FMTX in Q2 2020 and held it in 5 quarters. The position peaked at $1.29M in Q2 2020. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

Jane Street reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Jane Street sold 15,510 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $107K.
Jane Street first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Jane Street's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.29M in Q2 2020.
139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.